In all these experimental settings, ANT2 expression was significantly reduced relative to the respective controls (Supplemental Figure 1, C–H), suggesting a cellular mechanism linking mitochondrial dysfunction and obesity-induced CKD. Here, SLC25A5 is linked to obesity disorder.